|
Hemostasis, Thrombosis, and Vascular Biology
Citations 81-90 of 2496 total displayed.
|
Past content
(since Jan 1997):
|
Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura
- Jin Yu, Susanne Heck, Vivek Patel, Jared Levan, Yu Yu, James B. Bussel, and Karina Yazdanbakhsh
Blood 2008; 112: 1325-1328.
[Abstract]
[Full text]
[PDF]
Validation of PDGFRβ and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib
- Addolorata Maria Luce Coluccia, Teresa Cirulli, Paola Neri, Domenica Mangieri, Maria Cristina Colanardi, Antonio Gnoni, Nicola Di Renzo, Franco Dammacco, Pierfrancesco Tassone, Domenico Ribatti, Carlo Gambacorti-Passerini, and Angelo Vacca
Blood 2008; 112: 1346-1356.
[Abstract]
[Full text]
[PDF]
The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention
- David E. Gerber, Jodi B. Segal, M. Yair Levy, Joyce Kane, Richard J. Jones, and Michael B. Streiff
Blood 2008; 112: 504-510.
[Abstract]
[Full text]
[PDF]
Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study
- Sergio Siragusa, Alessandra Malato, Raffaela Anastasio, Valeria Cigna, Glauco Milio, Corrado Amato, Mario Bellisi, Maria Teresa Attanzio, Oreste Cormaci, Massimo Pellegrino, Alberto Dolce, Alessandra Casuccio, Guido Bajardi, and Guglielmo Mariani
Blood 2008; 112: 511-515.
[Abstract]
[Full text]
[PDF]
Interferon- 2b–induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes
- Akiko Yamane, Takanori Nakamura, Hidenori Suzuki, Mamoru Ito, Yasuyuki Ohnishi, Yasuo Ikeda, and Yoshitaka Miyakawa
Blood 2008; 112: 542-550.
[Abstract]
[Full text]
[PDF]
Maternal Par4 and platelets contribute to defective placenta formation in mouse embryos lacking thrombomodulin
- Rashmi Sood, Lynette Sholl, Berend Isermann, Mark Zogg, Shaun R. Coughlin, and Hartmut Weiler
Blood 2008; 112: 585-591.
[Abstract]
[Full text]
[PDF]
RGT, a synthetic peptide corresponding to the integrin β3 cytoplasmic C-terminal sequence, selectively inhibits outside-in signaling in human platelets by disrupting the interaction of integrin IIbβ3 with Src kinase
- Xiaoyu Su, Jianqing Mi, Jinsong Yan, Panagiotis Flevaris, Yuanjing Lu, Hongchen Liu, Zheng Ruan, Xuefeng Wang, Nelly Kieffer, Saijuan Chen, Xiaoping Du, and Xiaodong Xi
Blood 2008; 112: 592-602.
[Abstract]
[Full text]
[PDF]
Altered thrombus formation in von Willebrand factor–deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa
- Isabelle Marx, Olivier D. Christophe, Peter J. Lenting, Alain Rupin, Marie-Odile Vallez, Tony J. Verbeuren, and Cécile V. Denis
Blood 2008; 112: 603-609.
[Abstract]
[Full text]
[PDF]
Placenta growth factor augments endothelin-1 and endothelin-B receptor expression via hypoxia-inducible factor-1
- Nitin Patel, Caryn S. Gonsalves, Punam Malik, and Vijay K. Kalra
Blood 2008; 112: 856-865.
[Abstract]
[Full text]
[PDF]
High-dose compared with intermediate-dose methotrexate in children with a first relapse of acute lymphatic leukemia
- Ian J. Cohen
Blood 2008; 112: 910.
[Full text]
[PDF]
|
|
